nih-gov/www.ncbi.nlm.nih.gov/books/NBK541231/index.html?report=reader
2025-03-17 02:05:34 +00:00

188 lines
63 KiB
Text

<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" class="no-js no-jr">
<head>
<!-- For pinger, set start time and add meta elements. -->
<script type="text/javascript">var ncbi_startTime = new Date();</script>
<!-- Logger begin -->
<meta name="ncbi_db" content="books">
<meta name="ncbi_pdid" content="book-part">
<meta name="ncbi_acc" content="NBK541231">
<meta name="ncbi_domain" content="gene">
<meta name="ncbi_report" content="reader">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_objectid" content="">
<meta name="ncbi_pcid" content="/NBK541231/?report=reader">
<meta name="ncbi_pagename" content="Resources for Genetics Professionals &mdash; Genetic Disorders Associated with Founder Variants Common in the Cree and/or Ojibway Population - GeneReviews&reg; - NCBI Bookshelf">
<meta name="ncbi_bookparttype" content="appendix">
<meta name="ncbi_app" content="bookshelf">
<!-- Logger end -->
<!--component id="Page" label="meta"/-->
<script type="text/javascript" src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.boots.min.js"> </script><title>Resources for Genetics Professionals &mdash; Genetic Disorders Associated with Founder Variants Common in the Cree and/or Ojibway Population - GeneReviews&reg; - NCBI Bookshelf</title>
<meta charset="utf-8">
<meta name="apple-mobile-web-app-capable" content="no">
<meta name="viewport" content="initial-scale=1,minimum-scale=1,maximum-scale=1,user-scalable=no">
<meta name="jr-col-layout" content="auto">
<meta name="jr-prev-unit" content="/books/n/gene/founder_costa_rican/?report=reader">
<meta name="jr-next-unit" content="/books/n/gene/founder_druze/?report=reader">
<meta name="bk-toc-url" content="/books/n/gene/?report=toc">
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE">
<meta name="citation_inbook_title" content="GeneReviews&reg; [Internet]">
<meta name="citation_title" content="Resources for Genetics Professionals &mdash; Genetic Disorders Associated with Founder Variants Common in the Cree and/or Ojibway Population">
<meta name="citation_publisher" content="University of Washington, Seattle">
<meta name="citation_date" content="2023/06/01">
<meta name="citation_author" content="Stephanie E Wallace">
<meta name="citation_author" content="Lora JH Bean">
<meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK541231/">
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/">
<meta name="DC.Title" content="Resources for Genetics Professionals &mdash; Genetic Disorders Associated with Founder Variants Common in the Cree and/or Ojibway Population">
<meta name="DC.Type" content="Text">
<meta name="DC.Publisher" content="University of Washington, Seattle">
<meta name="DC.Contributor" content="Stephanie E Wallace">
<meta name="DC.Contributor" content="Lora JH Bean">
<meta name="DC.Date" content="2023/06/01">
<meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK541231/">
<meta name="description" content="A founder variant is a pathogenic variant observed at high frequency in a specific population due to the presence of the variant in a single ancestor or small number of ancestors. The presence of a founder variant can affect the approach to molecular genetic testing. When one or more founder variants account for a large percentage of all pathogenic variants found in a population, testing for the founder variant(s) may be performed first.">
<meta name="og:title" content="Resources for Genetics Professionals &mdash; Genetic Disorders Associated with Founder Variants Common in the Cree and/or Ojibway Population">
<meta name="og:type" content="book">
<meta name="og:description" content="A founder variant is a pathogenic variant observed at high frequency in a specific population due to the presence of the variant in a single ancestor or small number of ancestors. The presence of a founder variant can affect the approach to molecular genetic testing. When one or more founder variants account for a large percentage of all pathogenic variants found in a population, testing for the founder variant(s) may be performed first.">
<meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK541231/">
<meta name="og:site_name" content="NCBI Bookshelf">
<meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png">
<meta name="twitter:card" content="summary">
<meta name="twitter:site" content="@ncbibooks">
<meta name="bk-non-canon-loc" content="/books/n/gene/founder_cree_ojibway/?report=reader">
<link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK541231/">
<link href="https://fonts.googleapis.com/css?family=Archivo+Narrow:400,700,400italic,700italic&amp;subset=latin" rel="stylesheet" type="text/css">
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/libs.min.css">
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/jr.min.css">
<meta name="format-detection" content="telephone=no">
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css">
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css//books_print.min.css" type="text/css" media="print">
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_reader.min.css" type="text/css">
<style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style>
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico">
<meta name="ncbi_phid" content="CE8C97AF7D2A67C10000000000DB00B6.m_5">
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3849091.css"></head>
<body>
<!-- Book content! -->
<div id="jr" data-jr-path="/corehtml/pmc/jatsreader/ptpmc_3.22/"><div class="jr-unsupported"><table class="modal"><tr><td><span class="attn inline-block"></span><br />Your browser does not support the NLM PubReader view.<br />Go to <a href="/pmc/about/pr-browsers/">this page</a> to see a list of supported browsers<br />or return to the <br /><a href="/books/NBK541231/?report=classic">regular view</a>.</td></tr></table></div><div id="jr-ui" class="hidden"><nav id="jr-head"><div class="flexh tb"><div id="jr-tb1"><a id="jr-links-sw" class="hidden" title="Links"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" x="0px" y="0px" viewBox="0 0 70.6 85.3" style="enable-background:new 0 0 70.6 85.3;vertical-align:middle" xml:space="preserve" width="24" height="24">
<style type="text/css">.st0{fill:#939598;}</style>
<g>
<path class="st0" d="M36,0C12.8,2.2-22.4,14.6,19.6,32.5C40.7,41.4-30.6,14,35.9,9.8"></path>
<path class="st0" d="M34.5,85.3c23.2-2.2,58.4-14.6,16.4-32.5c-21.1-8.9,50.2,18.5-16.3,22.7"></path>
<path class="st0" d="M34.7,37.1c66.5-4.2-4.8-31.6,16.3-22.7c42.1,17.9,6.9,30.3-16.4,32.5h1.7c-66.2,4.4,4.8,31.6-16.3,22.7 c-42.1-17.9-6.9-30.3,16.4-32.5"></path>
</g>
</svg> Books</a></div><div class="jr-rhead f1 flexh"><div class="head"><a href="/books/n/gene/founder_costa_rican/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="body"><div class="t">Resources for Genetics Professionals &#x02014; Genetic Disorders Associated with Founder Variants Common in the Cree and/or Ojibway Population</div><div class="j">GeneReviews&#x000ae; [Internet]</div></div><div class="tail"><a href="/books/n/gene/founder_druze/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></div><div id="jr-tb2"><a id="jr-bkhelp-sw" class="btn wsprkl hidden" title="Help with NLM PubReader">?</a><a id="jr-help-sw" class="btn wsprkl hidden" title="Settings and typography in NLM PubReader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512" preserveAspectRatio="none"><path d="M462,283.742v-55.485l-29.981-10.662c-11.431-4.065-20.628-12.794-25.274-24.001 c-0.002-0.004-0.004-0.009-0.006-0.013c-4.659-11.235-4.333-23.918,0.889-34.903l13.653-28.724l-39.234-39.234l-28.72,13.652 c-10.979,5.219-23.68,5.546-34.908,0.889c-0.005-0.002-0.01-0.003-0.014-0.005c-11.215-4.65-19.933-13.834-24-25.273L283.741,50 h-55.484l-10.662,29.981c-4.065,11.431-12.794,20.627-24.001,25.274c-0.005,0.002-0.009,0.004-0.014,0.005 c-11.235,4.66-23.919,4.333-34.905-0.889l-28.723-13.653l-39.234,39.234l13.653,28.721c5.219,10.979,5.545,23.681,0.889,34.91 c-0.002,0.004-0.004,0.009-0.006,0.013c-4.649,11.214-13.834,19.931-25.271,23.998L50,228.257v55.485l29.98,10.661 c11.431,4.065,20.627,12.794,25.274,24c0.002,0.005,0.003,0.01,0.005,0.014c4.66,11.236,4.334,23.921-0.888,34.906l-13.654,28.723 l39.234,39.234l28.721-13.652c10.979-5.219,23.681-5.546,34.909-0.889c0.005,0.002,0.01,0.004,0.014,0.006 c11.214,4.649,19.93,13.833,23.998,25.271L228.257,462h55.484l10.595-29.79c4.103-11.538,12.908-20.824,24.216-25.525 c0.005-0.002,0.009-0.004,0.014-0.006c11.127-4.628,23.694-4.311,34.578,0.863l28.902,13.738l39.234-39.234l-13.66-28.737 c-5.214-10.969-5.539-23.659-0.886-34.877c0.002-0.005,0.004-0.009,0.006-0.014c4.654-11.225,13.848-19.949,25.297-24.021 L462,283.742z M256,331.546c-41.724,0-75.548-33.823-75.548-75.546s33.824-75.547,75.548-75.547 c41.723,0,75.546,33.824,75.546,75.547S297.723,331.546,256,331.546z"></path></svg></a><a id="jr-fip-sw" class="btn wsprkl hidden" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-rtoc-sw" class="btn wsprkl hidden" title="Table of Contents"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,20h10v8H20V20zM36,20h44v8H36V20zM20,37.33h10v8H20V37.33zM36,37.33h44v8H36V37.33zM20,54.66h10v8H20V54.66zM36,54.66h44v8H36V54.66zM20,72h10v8 H20V72zM36,72h44v8H36V72z"></path></svg></a></div></div></nav><nav id="jr-dash" class="noselect"><nav id="jr-dash" class="noselect"><div id="jr-pi" class="hidden"><a id="jr-pi-prev" class="hidden" title="Previous page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a><div class="pginfo">Page <i class="jr-pg-pn">0</i> of <i class="jr-pg-lp">0</i></div><a id="jr-pi-next" class="hidden" title="Next page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div><div id="jr-is-tb"><a id="jr-is-sw" class="btn wsprkl hidden" title="Switch between Figures/Tables strip and Progress bar"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><rect x="10" y="40" width="20" height="20"></rect><rect x="40" y="40" width="20" height="20"></rect><rect x="70" y="40" width="20" height="20"></rect></svg></a></div><nav id="jr-istrip" class="istrip hidden"><a id="jr-is-prev" href="#" class="hidden" title="Previous"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M80,40 60,65 80,90 70,90 50,65 70,40z M50,40 30,65 50,90 40,90 20,65 40,40z"></path><text x="35" y="25" textLength="60" style="font-size:25px">Prev</text></svg></a><a id="jr-is-next" href="#" class="hidden" title="Next"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,40 40,65 20,90 30,90 50,65 30,40z M50,40 70,65 50,90 60,90 80,65 60,40z"></path><text x="15" y="25" textLength="60" style="font-size:25px">Next</text></svg></a></nav><nav id="jr-progress"></nav></nav></nav><aside id="jr-links-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">NCBI Bookshelf</div></div><div class="cnt lol f1"><a href="/books/">Home</a><a href="/books/browse/">Browse All Titles</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://www.facebook.com/sharer/sharer.php?u=https://www.ncbi.nlm.nih.gov/books/NBK541231/"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24" preserveAspectRatio="none"><g><path d="M 17.996,32L 12,32 L 12,16 l-4,0 l0-5.514 l 4-0.002l-0.006-3.248C 11.993,2.737, 13.213,0, 18.512,0l 4.412,0 l0,5.515 l-2.757,0 c-2.063,0-2.163,0.77-2.163,2.209l-0.008,2.76l 4.959,0 l-0.585,5.514L 18,16L 17.996,32z"></path></g></svg> Share on Facebook</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://twitter.com/intent/tweet?url=https://www.ncbi.nlm.nih.gov/books/NBK541231/&amp;text=Resources%20for%20Genetics%20Professionals%20%02014%20Genetic%20Disorders%20Associated%20with%20Founder%20Variants%20Common%20in%20th..."><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24"><g><path d="M 32,6.076c-1.177,0.522-2.443,0.875-3.771,1.034c 1.355-0.813, 2.396-2.099, 2.887-3.632 c-1.269,0.752-2.674,1.299-4.169,1.593c-1.198-1.276-2.904-2.073-4.792-2.073c-3.626,0-6.565,2.939-6.565,6.565 c0,0.515, 0.058,1.016, 0.17,1.496c-5.456-0.274-10.294-2.888-13.532-6.86c-0.565,0.97-0.889,2.097-0.889,3.301 c0,2.278, 1.159,4.287, 2.921,5.465c-1.076-0.034-2.088-0.329-2.974-0.821c-0.001,0.027-0.001,0.055-0.001,0.083 c0,3.181, 2.263,5.834, 5.266,6.438c-0.551,0.15-1.131,0.23-1.73,0.23c-0.423,0-0.834-0.041-1.235-0.118 c 0.836,2.608, 3.26,4.506, 6.133,4.559c-2.247,1.761-5.078,2.81-8.154,2.81c-0.53,0-1.052-0.031-1.566-0.092 c 2.905,1.863, 6.356,2.95, 10.064,2.95c 12.076,0, 18.679-10.004, 18.679-18.68c0-0.285-0.006-0.568-0.019-0.849 C 30.007,8.548, 31.12,7.392, 32,6.076z"></path></g></svg> Share on Twitter</a></div></aside><aside id="jr-rtoc-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Table of Content</div></div><div class="cnt lol f1"><a href="/books/n/gene/?report=reader">Title Information</a><a href="/books/n/gene/toc/?report=reader">Table of Contents Page</a></div></aside><aside id="jr-help-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Settings</div></div><div class="cnt f1"><div id="jr-typo-p" class="typo"><div><a class="sf btn wsprkl">A-</a><a class="lf btn wsprkl">A+</a></div><div><a class="bcol-auto btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 200 100" preserveAspectRatio="none"><text x="10" y="70" style="font-size:60px;font-family: Trebuchet MS, ArialMT, Arial, sans-serif" textLength="180">AUTO</text></svg></a><a class="bcol-1 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M15,25 85,25zM15,40 85,40zM15,55 85,55zM15,70 85,70z"></path></svg></a><a class="bcol-2 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M5,25 45,25z M55,25 95,25zM5,40 45,40z M55,40 95,40zM5,55 45,55z M55,55 95,55zM5,70 45,70z M55,70 95,70z"></path></svg></a></div></div><div class="lol"><a class="" href="/books/NBK541231/?report=classic">Switch to classic view</a><a href="/books/NBK541231/pdf/Bookshelf_NBK541231.pdf">PDF (126K)</a><a href="/books/NBK541231/?report=printable">Print View</a></div></div></aside><aside id="jr-bkhelp-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Help</div></div><div class="cnt f1 lol"><a id="jr-helpobj-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/help.xml" href="">Help</a><a href="mailto:info@ncbi.nlm.nih.gov?subject=PubReader%20feedback%20%2F%20NBK541231%20%2F%20sid%3ACE8B5AF87C7FFCB1_0191SID%20%2F%20phid%3ACE8C97AF7D2A67C10000000000DB00B6.4">Send us feedback</a><a id="jr-about-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/about.xml" href="">About PubReader</a></div></aside><aside id="jr-objectbox" class="thidden hidden"><div class="jr-objectbox-close wsprkl">&#10008;</div><div class="jr-objectbox-inner cnt"><div class="jr-objectbox-drawer"></div></div></aside><nav id="jr-pm-left" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Previous Page</text></svg></nav><nav id="jr-pm-right" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Next Page</text></svg></nav><nav id="jr-fip" class="hidden"><nav id="jr-fip-term-p"><input type="search" placeholder="search this page" id="jr-fip-term" autocorrect="off" autocomplete="off" /><a id="jr-fip-mg" class="wsprkl btn" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-fip-done" class="wsprkl btn" title="Dismiss find">&#10008;</a></nav><nav id="jr-fip-info-p"><a id="jr-fip-prev" class="wsprkl btn" title="Jump to previuos match">&#9664;</a><button id="jr-fip-matches">no matches yet</button><a id="jr-fip-next" class="wsprkl btn" title="Jump to next match">&#9654;</a></nav></nav></div><div id="jr-epub-interstitial" class="hidden"></div><div id="jr-content"><article data-type="main"><div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><div class="fm-sec"><h1 id="_NBK541231_"><span class="title" itemprop="name">Resources for Genetics Professionals &#x02014; Genetic Disorders Associated with Founder Variants Common in the Cree and/or Ojibway Population</span></h1><p class="contribs">Wallace SE, Bean LJH.</p><p class="fm-aai"><a href="#_NBK541231_pubdet_">Publication Details</a></p><p><em>Estimated reading time: 3 minutes</em></p></div></div><div class="body-content whole_rhythm" itemprop="text"><p>A founder variant is a pathogenic variant observed at high frequency in a specific population due to the presence of the variant in a single ancestor or small number of ancestors. The presence of a founder variant can affect the approach to molecular genetic testing. When one or more founder variants account for a large percentage of all pathogenic variants found in a population, testing for the founder variant(s) may be performed first.</p><p>The table below includes common founder variants &#x02013; here defined as <b>three or fewer variants that account for &#x0003e;50% of the pathogenic variants identified in a single gene in individuals of a specific ancestry</b> &#x02013; in individuals of Cree and/or Ojibway ancestry. Note: Pathogenic variants that are common worldwide due to a DNA sequence hot spot are not considered founder variants and thus are not included.</p><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figfoundercreeojibwayTgeneticdisorders"><a href="/books/NBK541231/table/founder_cree_ojibway.T.genetic_disorders/?report=objectonly" target="object" title="Table. " class="img_link icnblk_img" rid-ob="figobfoundercreeojibwayTgeneticdisorders"><img class="small-thumb" src="/corehtml/pmc/css/bookshelf/2.26/img/table-icon.gif" alt="Table Icon" /></a><div class="icnblk_cntnt"><h4 id="founder_cree_ojibway.T.genetic_disorders"><a href="/books/NBK541231/table/founder_cree_ojibway.T.genetic_disorders/?report=objectonly" target="object" rid-ob="figobfoundercreeojibwayTgeneticdisorders">Table. </a></h4><p class="float-caption no_bottom_margin">Genetic Disorders Associated with Founder Variants Common in the Cree and/or Ojibway Population </p></div></div><div id="founder_cree_ojibway.References"><h2 id="_founder_cree_ojibway_References_">References</h2><ul class="simple-list"><li class="half_rhythm"><p><div class="bk_ref" id="founder_cree_ojibway.REF.attanasio.2007.1018">Attanasio M, Uhlenhaut NH, Sousa VH, O'Toole JF, Otto E, Anlag K, Klugmann C, Treier AC, Helou J, Sayer JA, Seelow D, N&#x000fc;rnberg G, Becker C, Chudley AE, N&#x000fc;rnberg P, Hildebrandt F, Treier M. Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis. <span><span class="ref-journal">Nature Genet. </span>2007;<span class="ref-vol">39</span>:1018&ndash;24.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17618285" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17618285</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="founder_cree_ojibway.REF.carbone.1998.1312">Carbone MA, MacKay N, Ling M, Cole DE, Douglas C, Rigat B, Feigenbaum A, Clarke JT, Haworth JC, Greenberg CR, Seargeant L, Robinson BH. Amerindian pyruvate carboxylase deficiency is associated with two distinct missense mutations. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">62</span>:1312&ndash;9.</span> [<a href="/pmc/articles/PMC1377163/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377163</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9585612" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9585612</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="founder_cree_ojibway.REF.crow.2003.183">Crow YJ, Black DN, Ali M, Bond J, Jackson AP, Lefson M, Michaud J, Roberts E, Stephenson JB, Woods CG, Lebon P. Cree encephalitis is allelic with Aicardi-Goutieres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism. <span><span class="ref-journal">J. Med. Genet. </span>2003;<span class="ref-vol">40</span>:183&ndash;7.</span> [<a href="/pmc/articles/PMC1735395/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735395</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12624136" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12624136</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="founder_cree_ojibway.REF.crow.2006.917">Crow YJ, Hayward BE, Parmar R, Robins P, Leitch A, Ali M, Black DN, van Bokhoven H, Brunner HG, Hamel BC, Corry PC, Cowan FM, Frints SG, Klepper J, Livingston JH, Lynch SA, Massey RF, Meritet JF, Michaud JL, Ponsot G, Voit T, Lebon P, Bonthron DT, Jackson AP, Barnes DE, Lindahl T. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Gouti&#x000e8;res syndrome at the AGS1 locus. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:917&ndash;20.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16845398" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16845398</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="founder_cree_ojibway.REF.del_bigio.2011.866">Del Bigio MR, Chudley AE, Sarnat HB, Campbell C, Goobie S, Chodirker BN, Selcen D. Infantile muscular dystrophy in Canadian aboriginals is an alpha-B-crystallinopathy. <span><span class="ref-journal">Ann Neurol. </span>2011;<span class="ref-vol">69</span>:866&ndash;71.</span> [<a href="/pmc/articles/PMC3085857/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3085857</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21337604" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21337604</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="founder_cree_ojibway.REF.evrony.2017.1323">Evrony GD, Cordero DR, Shen J, Partlow JN, Yu TW, Rodin RE, Hill RS, Coulter ME, Lam AN, Jayaraman D, Gerrelli D, Diaz DG, Santos C, Morrison V, Galli A, Tschulena U, Wiemann S, Martel MJ, Spooner B, Ryu SC, Elhosary PC, Richardson JM, Tierney D, Robinson CA, Chibbar R, Diudea D, Folkerth R, Wiebe S, Barkovich AJ, Mochida GH, Irvine J, Lemire EG, Blakley P, Walsh CA. Integrated genome and transcriptome sequencing identifies a noncoding mutation in the genome replication factor DONSON as the cause of microcephaly-micromelia syndrome. <span><span class="ref-journal">Genome Res. </span>2017;<span class="ref-vol">27</span>:1323&ndash;35.</span> [<a href="/pmc/articles/PMC5538549/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5538549</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28630177" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28630177</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="founder_cree_ojibway.REF.fogli.2002.506">Fogli A, Wong K, Eymard-Pierre E, Wenger J, Bouffard JP, Goldin E, Black DN, Boespflug-Tanguy O, Schiffmann R. Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus. <span><span class="ref-journal">Ann Neurol. </span>2002;<span class="ref-vol">52</span>:506&ndash;10.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12325082" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12325082</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="founder_cree_ojibway.REF.greenberg.2002.70">Greenberg CR, Prasad AN, Dilling LA, Thompson JR, Haworth JC, Martin B, Wood-Steiman P, Seargeant LE, Seifert B, Booth FA, Prasad C. Outcome of the first 3-years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and northwestern Ontario, Canada. <span><span class="ref-journal">Mol Genet Metab. </span>2002;<span class="ref-vol">75</span>:70&ndash;8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11825066" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11825066</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="founder_cree_ojibway.REF.hartley.2019.206">Hartley JN, Simard LR, Ly V, Del Bigio MR, Frosk P. A homozygous canonical splice acceptor site mutation in PRUNE1 is responsible for a rare childhood neurodegenerative disease in Manitoba Cree families. <span><span class="ref-journal">Am J Med Genet A. </span>2019;<span class="ref-vol">179</span>:206&ndash;18.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30556349" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30556349</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="founder_cree_ojibway.REF.pannicke.2013.2504">Pannicke U, Baumann B, Fuchs S, Henneke P, Rensing-Ehl A, Rizzi M, Janda A, Hese K, Schlesier M, Holzmann K, Borte S, Laux C, Rump EM, Rosenberg A, Zelinski T, Schrezenmeier H, Wirth T, Ehl S, Schroeder ML, Schwarz K. Deficiency of innate and acquired immunity caused by an IKBKB mutation. <span><span class="ref-journal">N Engl J Med. </span>2013;<span class="ref-vol">369</span>:2504&ndash;14.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24369075" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24369075</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="founder_cree_ojibway.REF.rubin.2018.742">Rubin TS, Rockman-Greenberg C, Van Caeseele P, Cuvelier GDE, Kwan L, Schroeder ML. Newborn screening for IKBKB deficiency in Manitoba, using genetic mutation analysis. <span><span class="ref-journal">J Clin Immunol. </span>2018;<span class="ref-vol">38</span>:742&ndash;4.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30288645" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30288645</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="founder_cree_ojibway.REF.slavotinek.2011.375">Slavotinek AM, Baranzini SE, Schanze D, Labelle-Dumais C, Short KM, Chao R, Yahyavi M, Bijlsma EK, Chu C, Musone S, Wheatley A, Kwok PY, Marles S, Fryns JP, Maga AM, Hassan MG, Gould DB, Madireddy L, Li C, Cox TC, Smyth I, Chudley AE, Zenker M. Manitoba-oculo-tricho-anal (MOTA) syndrome is caused by mutations in FREM1. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:375&ndash;82.</span> [<a href="/pmc/articles/PMC4294942/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4294942</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21507892" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21507892</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="founder_cree_ojibway.REF.uminski.2020.e28623">Uminski K, Houston DS, Hartley JN, Liu J, Cuvelier GDE, Israels SJ. Clinical characterization and hematopoietic stem cell transplant outcomes for congenital sideroblastic anemia caused by a novel pathogenic variant in SLC25A38. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2020;<span class="ref-vol">67</span>:e28623. </span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32790119" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 32790119</span></a>]</div></p></li></ul></div><div id="founder_cree_ojibway.Revision_History"><h2 id="_founder_cree_ojibway_Revision_History_">Revision History</h2><ul><li class="half_rhythm"><div>1 June 2023 (sw) Revision: added sideroblastic anemia 2</div></li><li class="half_rhythm"><div>16 January 2020 (sw) Revision: added glutaric acidemia type 1</div></li><li class="half_rhythm"><div>16 May 2019 (sw) Initial posting</div></li></ul></div><div id="bk_toc_contnr"></div></div></div><div class="fm-sec"><h2 id="_NBK541231_pubdet_">Publication Details</h2><h3>Author Information and Affiliations</h3><div class="contrib half_rhythm"><span itemprop="author">Stephanie E Wallace</span>, MD<div class="affiliation small">Senior Editor, <i>GeneReviews</i></div><div class="affiliation small">Clinical Professor, Department of Pediatrics<br />University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@2rotide" class="oemail">ude.wu@2rotide</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Lora JH Bean</span>, PhD<div class="affiliation small">Molecular Genetics Editor, <i>GeneReviews</i></div><div class="affiliation small">Senior Director, Laboratory Quality Assurance<br />Perkin-Elmer Genomics, Inc<br />Pittsburgh, Pennsylvania</div></div><h3>Publication History</h3><p class="small">Initial Posting: <span itemprop="datePublished">May 16, 2019</span>; Last Revision: <span itemprop="dateModified">June 1, 2023</span>.</p><h3>Copyright</h3><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> &#x000a9; 1993-2025, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (&#x000a9; 1993-2025 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="https://www.ncbi.nlm.nih.gov/books/n/gene/GRcopyright_permiss/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GeneReviews&#x000ae; Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="https://www.ncbi.nlm.nih.gov/books/n/gene/GRcopyright_permiss/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GeneReviews&#x000ae; Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div></div><h3>Publisher</h3><p><a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>, Seattle (WA)</p><h3>NLM Citation</h3><p>Wallace SE, Bean LJH. Resources for Genetics Professionals &#x02014; Genetic Disorders Associated with Founder Variants Common in the Cree and/or Ojibway Population. 2019 May 16 [Updated 2023 Jun 1]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews&#x000ae; [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. <span class="bk_cite_avail"></span></p></div><div class="small-screen-prev"><a href="/books/n/gene/founder_costa_rican/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="small-screen-next"><a href="/books/n/gene/founder_druze/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></article><article data-type="table-wrap" id="figobfoundercreeojibwayTgeneticdisorders"><div id="founder_cree_ojibway.T.genetic_disorders" class="table"><h3><span class="label">Table. </span></h3><div class="caption"><p>Genetic Disorders Associated with Founder Variants Common in the Cree and/or Ojibway Population</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541231/table/founder_cree_ojibway.T.genetic_disorders/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__founder_cree_ojibway.T.genetic_disorders_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">% of Pathogenic Variants in Gene&#x000a0;<sup>2&#x000a0;,3</sup></th><th id="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Carrier Frequency</th><th id="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_8" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ethnicity<br />(Specific Region of Canada)</th><th id="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_9" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference<br />Sequences</th><th id="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_10" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference(s)</th></tr></thead><tbody><tr><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<i>CRYAB</i>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fatal infantile myofibrillar myopathy (OMIM <a href="https://omim.org/entry/613869" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613869</a>)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.60delC</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser21AlafsTer24</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cree<br />(N Ontario &#x00026; Alberta)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001885.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001885<wbr style="display:inline-block"></wbr>&#8203;.3</a>
<br />
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_001876.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001876<wbr style="display:inline-block"></wbr>&#8203;.1</a>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a class="bibr" href="#founder_cree_ojibway.REF.del_bigio.2011.866" rid="founder_cree_ojibway.REF.del_bigio.2011.866">Del Bigio et al [2011]</a>
</td></tr><tr><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<i>DONSON</i>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Microcephaly-micromelia syndrome (OMIM <a href="https://omim.org/entry/251230" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">251230</a>)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1047-9A&#x0003e;G<br />(IVS6-9A&#x0003e;G)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cree<br />(N Saskatchewan)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_017613.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_017613<wbr style="display:inline-block"></wbr>&#8203;.4</a>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a class="bibr" href="#founder_cree_ojibway.REF.evrony.2017.1323" rid="founder_cree_ojibway.REF.evrony.2017.1323">Evrony et al [2017]</a>
</td></tr><tr><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<i>EIF2B5</i>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cree leukoencephalopathy (See <a href="/books/n/gene/cach/?report=reader">Childhood Ataxia with Central Nervous System Hypomyelination&#x000a0;/ Vanishing White Matter</a>.)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.584G&#x0003e;A</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg195His</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/10</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cree<br />(N Quebec &#x00026; Manitoba)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_003907.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003907<wbr style="display:inline-block"></wbr>&#8203;.3</a>
<br />
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_003898.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_003898<wbr style="display:inline-block"></wbr>&#8203;.2</a>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a class="bibr" href="#founder_cree_ojibway.REF.fogli.2002.506" rid="founder_cree_ojibway.REF.fogli.2002.506">Fogli et al [2002]</a>
</td></tr><tr><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<i>FREM1</i>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manitoba oculotrichoanal syndrome (See <a href="/books/n/gene/mota/?report=reader"><i>FREM1</i> Autosomal Recessive Disorders</a>.)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.824+627_c.3840-1311del<br />(IVS7+631_IVS23-1311 del; del8-23 exon)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.385_1327del</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/7 to 1/12</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ojibway-Cree<br />(Island Lake, Manitoba)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_144966.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_144966<wbr style="display:inline-block"></wbr>&#8203;.5</a>
<br />
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_659403.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_659403<wbr style="display:inline-block"></wbr>&#8203;.4</a>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a class="bibr" href="#founder_cree_ojibway.REF.slavotinek.2011.375" rid="founder_cree_ojibway.REF.slavotinek.2011.375">Slavotinek et al [2011]</a>
</td></tr><tr><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<i>GCDH</i>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a href="/books/n/gene/glutaric-a1/?report=reader">Glutaric acidemia type 1</a>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.91+5G&#x0003e;T<br />(IVS2+5G&#x0003e;T)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/17</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ojibway-Cree<br />(Island Lake, Manitoba, &#x00026; NW Ontario)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000159.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000159<wbr style="display:inline-block"></wbr>&#8203;.4</a>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a class="bibr" href="#founder_cree_ojibway.REF.greenberg.2002.70" rid="founder_cree_ojibway.REF.greenberg.2002.70">Greenberg et al [2002]</a>
</td></tr><tr><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<i>GLIS2</i>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a href="/books/n/gene/nephron-ov/?report=reader">Nephronophthisis-related ciliopathies</a>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.775+1G&#x0003e;T<br />(IVS5+1G&#x0003e;T)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ojibway-Cree<br />(Canada)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_032575.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_032575<wbr style="display:inline-block"></wbr>&#8203;.3</a>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a class="bibr" href="#founder_cree_ojibway.REF.attanasio.2007.1018" rid="founder_cree_ojibway.REF.attanasio.2007.1018">Attanasio et al [2007]</a>
</td></tr><tr><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<i>IKBKB</i>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Immunodeficiency 15B (OMIM <a href="https://omim.org/entry/615592" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615592</a>)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1292dupG</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln432ProfsTer62</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/13</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cree<br />(Manitoba &#x00026; Saskatchewan)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001556.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001556<wbr style="display:inline-block"></wbr>&#8203;.3</a>
<br />
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_001547.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001547<wbr style="display:inline-block"></wbr>&#8203;.1</a>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bibr" href="#founder_cree_ojibway.REF.pannicke.2013.2504" rid="founder_cree_ojibway.REF.pannicke.2013.2504">Pannicke et al [2013]</a>, <a class="bibr" href="#founder_cree_ojibway.REF.rubin.2018.742" rid="founder_cree_ojibway.REF.rubin.2018.742">Rubin et al [2018]</a></td></tr><tr><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<i>PC</i>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a href="/books/n/gene/pdc/?report=reader">Pyruvate carboxylase deficiency</a>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1828G&#x0003e;A</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala610Thr</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Up to 1/10</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ojibway-Cree<br />(White Dog, Ontario)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000920.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000920<wbr style="display:inline-block"></wbr>&#8203;.4</a>
<br />
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000911.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000911<wbr style="display:inline-block"></wbr>&#8203;.2</a>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a class="bibr" href="#founder_cree_ojibway.REF.carbone.1998.1312" rid="founder_cree_ojibway.REF.carbone.1998.1312">Carbone et al [1998]</a>
</td></tr><tr><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<i>PRUNE1</i>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurodevelopmental disorder with microcephaly, hypotonia, &#x00026; variable brain anomalies (OMIM <a href="https://omim.org/entry/617481" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">617481</a>)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.521-2A&#x0003e;G<br />(IVS4-2A&#x0003e;G)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cree<br />(N Manitoba)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_021222.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_021222<wbr style="display:inline-block"></wbr>&#8203;.3</a>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a class="bibr" href="#founder_cree_ojibway.REF.hartley.2019.206" rid="founder_cree_ojibway.REF.hartley.2019.206">Hartley et al [2019]</a>
</td></tr><tr><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<i>SLC25A38</i>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sideroblastic anemia 2 (OMIM <a href="https://omim.org/entry/205950" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">205950</a>)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.560G&#x0003e;A</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg187Gln</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cree<br />(Canada)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_017875.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_017875<wbr style="display:inline-block"></wbr>&#8203;.4</a>
<br />
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_060345.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_060345<wbr style="display:inline-block"></wbr>&#8203;.2</a>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a class="bibr" href="#founder_cree_ojibway.REF.uminski.2020.e28623" rid="founder_cree_ojibway.REF.uminski.2020.e28623">Uminski et al [2020]</a>
</td></tr><tr><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<i>TREX1</i>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cree encephalitis (See <a href="/books/n/gene/ags/?report=reader">Aicardi-Gouti&#x000e8;res Syndrome</a>.)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.490C&#x0003e;T</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg164Ter</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/10</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cree<br />(Quebec)</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_033629.6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_033629<wbr style="display:inline-block"></wbr>&#8203;.6</a>
<br />
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_338599.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_338599<wbr style="display:inline-block"></wbr>&#8203;.1</a>
</td><td headers="hd_h_founder_cree_ojibway.T.genetic_disorders_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bibr" href="#founder_cree_ojibway.REF.crow.2003.183" rid="founder_cree_ojibway.REF.crow.2003.183">Crow et al [2003]</a>, <a class="bibr" href="#founder_cree_ojibway.REF.crow.2006.917" rid="founder_cree_ojibway.REF.crow.2006.917">Crow et al [2006]</a></td></tr></tbody></table></div><div class="tblwrap-foot"><div><dl class="temp-labeled-list small"><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_margin">Included if &#x02264;3 pathogenic variants account for &#x02265;50% of variants identified in a specific ethnic group</p></div></dd></dl><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_margin">AR = autosomal recessive; MOI = mode of inheritance; N = Northern; NW = Northwest</p></div></dd></dl><dl class="bkr_refwrap"><dt>1. </dt><dd><div id="founder_cree_ojibway.TF.e.1"><p class="no_margin">Does not conform to standard HGVS nomenclature</p></div></dd></dl><dl class="bkr_refwrap"><dt>2. </dt><dd><div id="founder_cree_ojibway.TF.e.2"><p class="no_margin">This percentage does not account for the possibility of rare <i>de novo</i> pathogenic variants occurring in this population.</p></div></dd></dl><dl class="bkr_refwrap"><dt>3. </dt><dd><div id="founder_cree_ojibway.TF.e.3"><p class="no_margin">To date, additional pathogenic variants in this gene have not been reported in individuals of Cree and/or Ojibway descent (from region specified).</p></div></dd></dl></dl></div></div></div></article></div><div id="jr-scripts"><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/libs.min.js"> </script><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.min.js"> </script><script type="text/javascript">if (typeof (jQuery) != 'undefined') { (function ($) { $(function () { var min = Math.ceil(1); var max = Math.floor(100000); var randomNum = Math.floor(Math.random() * (max - min)) + min; var surveyUrl = "/projects/Gene/portal/surveys/seqdbui-survey.js?rando=" + randomNum.toString(); $.getScript(surveyUrl, function () { try { ncbi.seqDbUISurvey.init(); } catch (err) { console.info(err); } }).fail(function (jqxhr, settings, exception) { console.info('Cannot load survey script', jqxhr); });; }); })(jQuery); };</script></div></div>
<!-- Book content -->
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal105 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3968615.js" snapshot="books"></script></body>
</html>